80064-141-02 : NDC 2026 Code

80064-141-02 : Bremelanotide ( Vyleesi )

Additionally :

You can get information about “80064-141-02” NDC code in 80064-141-02 in HTML format

HTML | 80064-141-02 in TXT (Plain Text) format

TXT | 80064-141-02 in PDF (Portable Document Format)

PDF | 80064-141-02 in XML format

XML formats.

NDC Code : 80064-141-02 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "80064-141-02",
    "PackageDescription": "2 SYRINGE in 1 CARTON (80064-141-02)  / .3 mL in 1 SYRINGE (80064-141-01) ",
    "NDC11Code": "80064-0141-02",
    "ProductNDC": "80064-141",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Vyleesi",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Bremelanotide",
    "DosageFormName": "INJECTION",
    "RouteName": "SUBCUTANEOUS",
    "StartMarketingDate": "20190621",
    "EndMarketingDate": "20260701",
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA210557",
    "LabelerName": "Palatin Technologies",
    "SubstanceName": "BREMELANOTIDE ACETATE",
    "StrengthNumber": "1.75",
    "StrengthUnit": "mg/.3mL",
    "Pharm_Classes": "Melanocortin Receptor Agonist [EPC], Melanocortin Receptor Agonists [MoA]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-01-14",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": null,
    "StartMarketingDatePackage": "20190621",
    "EndMarketingDatePackage": "20260701",
    "SamplePackage": "N"
  }
}